Sanjay Rai Krishna Ella India Germany city Delhi vaccine Immunic Provident Sanjay Rai Krishna Ella India Germany city Delhi

Covid-19: Bharat Biotech expects DCGI’s nod for nasal vaccine this month

Reading now: 220
www.livemint.com

intranasal Covid-19 vaccine in August this year, informed Chairman and Managing Director of BBIL, Krishna Ella as quoted by news agency PTI.

He said that the vaccine manufacturing plant of BBIL (Bharat Biotech International Limited) in Gujarat's Ankleshwar is one of the two plants in the world that can manufacture monkeypox vaccine.

BBIL's another plant is in Bavarian Nordic, Germany. In a recently held event, Ella said that the drug development organization will be applying for licenses and expecting a positive response. "We know that by August this year, people would get the coronavirus vaccine, if everything goes well," he stated.

He informed that if any new variant comes, it will be easy to plug in quickly and move fast, hence the BBIL is optimistic that both injectable and nasal strategy will work protecting people's lives in the future.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA